These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the thought of focusing on ACKR3 as a unique strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-associated disorders. By ticking this box and https://immanuelm738ckt1.wikigiogio.com/user